🧬
Gen Terapisi Sektörü Hisseleri
Gen Terapisi Sektörü altında 55 Hisse Senedi
Gen Terapisi sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
55
Toplam Hisse
$37.6B
Toplam Piyasa Değeri
Gen Terapisi Sektörü Hisseleri
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | $6.32B | $218.00 | 0.32% |
| ACLX | Arcellx, Inc. | $4.03B | $72.71 | 0.74% |
| DYN | Dyne Therapeutics, Inc. | $3.13B | $21.90 | 3.45% |
| BEAM | Beam Therapeutics Inc. | $2.57B | $25.33 | 1.20% |
| LEGN | Legend Biotech Corporation | $2.55B | $27.71 | 0.76% |
| SRPT | Sarepta Therapeutics, Inc. | $2.09B | $21.32 | 1.79% |
| STOK | Stoke Therapeutics, Inc. | $1.77B | $30.91 | 0.96% |
| TSHA | Taysha Gene Therapies, Inc. | $1.24B | $4.74 | 2.47% |
| SANA | Sana Biotechnology, Inc. | $1.14B | $4.30 | 6.97% |
| IOVA | Iovance Biotherapeutics, Inc. | $819.27M | $2.47 | 1.23% |
| REPL | Replimune Group, Inc. | $784.40M | $10.00 | 0.60% |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | $719.65M | $9.86 | 2.39% |
| RGNX | REGENXBIO Inc. | $677.79M | $13.39 | 0.98% |
| PRME | Prime Medicine, Inc. | $676.15M | $3.82 | 2.96% |
| MGTX | MeiraGTx Holdings plc | $668.07M | $8.30 | 1.22% |
| FULC | Fulcrum Therapeutics, Inc. | $591.98M | $10.94 | 3.36% |
| FDMT | 4D Molecular Therapeutics, Inc. | $544.55M | $11.66 | 6.10% |
| DSGN | Design Therapeutics, Inc. | $534.86M | $9.39 | 0.21% |
| LYEL | Lyell Immunopharma, Inc. | $509.23M | $24.00 | 1.68% |
| PEPG | PepGen Inc. | $443.02M | $6.45 | 5.83% |
| SLDB | Solid Biosciences Inc. | $423.05M | $5.43 | 1.31% |
| TRDA | Entrada Therapeutics, Inc. | $392.51M | $10.27 | 1.88% |
| RCKT | Rocket Pharmaceuticals, Inc. | $371.74M | $3.44 | 4.41% |
| BNTC | Benitec Biopharma Inc. | $340.16M | $12.96 | 0.42% |
| KYTX | Kyverna Therapeutics, Inc. | $335.88M | $7.67 | 0.13% |
| ALLO | Allogene Therapeutics, Inc. | $328.11M | $1.46 | 2.82% |
| NGNE | Neurogene Inc. | $326.52M | $21.08 | 0.43% |
| LRMR | Larimar Therapeutics, Inc. | $302.99M | $3.54 | 0.28% |
| TSVT | 2seventy bio, Inc. | $266.14M | $5.00 | 0.00% |
| ABEO | Abeona Therapeutics Inc. | $253.50M | $5.07 | 1.55% |
| CABA | Cabaletta Bio, Inc. | $247.40M | $2.57 | 8.44% |
| TNYA | Tenaya Therapeutics, Inc. | $233.11M | $1.40 | 2.94% |
| CRGX | CARGO Therapeutics, Inc. Common Stock | $216.19M | $4.47 | 0.00% |
| EDIT | Editas Medicine, Inc. | $205.11M | $2.41 | 0.42% |
| RNAC | Cartesian Therapeutics, Inc. | $194.77M | $7.49 | 1.45% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $184.19M | $6.79 | 0.15% |
| SGMO | Sangamo Therapeutics, Inc. | $155.29M | $0.46 | 0.56% |
| NKTX | Nkarta, Inc. | $133.89M | $1.89 | 3.01% |
| FATE | Fate Therapeutics, Inc. | $131.47M | $1.14 | 3.64% |
| ATRA | Atara Biotherapeutics, Inc. | $108.86M | $15.10 | 1.62% |
| ARTV | Artiva Biotherapeutics, Inc. | $92.29M | $3.76 | 5.03% |
| ADVM | Adverum Biotechnologies, Inc. | $90.96M | $4.12 | 0.96% |
| TIL | Instil Bio, Inc. | $86.50M | $12.76 | 6.47% |
| DTIL | Precision BioSciences, Inc. | $72.11M | $5.44 | 6.46% |
| ACET | Adicet Bio, Inc. | $53.98M | $0.65 | 7.85% |
| KRRO | Korro Bio, Inc. | $53.45M | $5.70 | 3.26% |
| INKT | MiNK Therapeutics, Inc. | $49.34M | $10.51 | 5.82% |
| BLUE | bluebird bio, Inc. | $48.67M | $4.97 | 0.00% |
| GBIO | Generation Bio Co. | $35.91M | $5.33 | 0.57% |
| PASG | Passage Bio, Inc. | $28.07M | $8.83 | 1.78% |
| PHIO | Phio Pharmaceuticals Corp. | $13.67M | $1.27 | 3.25% |
| ERNA | Eterna Therapeutics Inc. | $10.60M | $1.35 | 2.17% |
| TCRT | Alaunos Therapeutics, Inc. | $7.30M | $3.27 | 2.68% |
| GNPX | Genprex, Inc. | $4.83M | $2.96 | 2.07% |
| CARM | Carisma Therapeutics, Inc. | $2.09M | $0.05 | 11.11% |